Swiss basic insurance (KVG) is designed to pay for the diagnosis and treatment of illness, plus a defined set of prevention measures. Comprehensive preventive blood screening for healthy adults falls outside that design.
How the KVG decides
Services paid by basic insurance must be effective, appropriate and economical [KVG Art. 32]. For prevention, basic insurance pays only the measures on a closed list in the KLV (Articles 12a to 12e), such as certain vaccinations and screening programs. Preventive or pre-symptomatic laboratory tests that are not on this list cannot be paid by basic insurance [BAG; BAG circular].
What this means for you
If you have symptoms or a known risk, your doctor can order the tests needed and they are covered under the usual cost-sharing. A broad baseline panel without a medical reason is self-paid. Some supplementary insurers contribute to check-ups; check your policy, see the reimbursement guide.
Why people still choose a broad panel
Some risks stay silent for years. Lp(a), for example, is largely inherited, about 1 in 5 people have raised levels, and European guidelines recommend measuring it at least once in adulthood [EAS 2022].
Plans: Prime Health CHF 649, Vital Edge CHF 859, Longevity Plus CHF 1,079 and Elite CHF 1,399, each per year including VAT. See the cost overview.
Frequently asked questions
Why does basic insurance not pay for preventive blood tests?
It pays only for prevention measures on a closed list in the KLV; other preventive tests in healthy adults are excluded.
When are blood tests covered?
When a doctor orders them for symptoms or a medical reason, subject to the usual deductible and co-payment.
Does supplementary insurance help?
Some supplementary plans contribute to check-ups. Check your policy before booking.
Sources
- Bundesgesetz über die Krankenversicherung (KVG), SR 832.10, Art. 32 (wirksam, zweckmässig, wirtschaftlich)
- BAG: Krankenversicherung, Massnahmen der medizinischen Prävention (KLV Art. 12a-12e)
- BAG: Rundschreiben zur Kostenübernahme von präventiven und präsymptomatischen Analysen
- Comparis: Was die Grundversicherung zahlt (KVG, KVV, KLV)
- Kronenberg F et al. Lipoprotein(a) in atherosclerotic cardiovascular disease: EAS consensus statement. Eur Heart J 2022
Aeonix: Own Your Health
Up to 150+ clinically validated biomarkers. Physician-reviewed results in 48–72 hours. Renowned Swiss lab. GDPR-compliant.
Join Waitlist Now